I hope you'll pardon me if I remain somewhat skeptical of your analysis, but I noticed some things about your past posts and tweets:
1) You always refer to your "girlfriend" as "her" and "she," but never call her by name. Most people with a loved one at least occasionally call them by their name when discussing them. I also notice that -- apparently -- "she," herself, never has anything to say about afrezza or diabetes. It's always you who makes the comments.
2) I notice that you tweet very often about afrezza:
Indeed, you appear to have tweeted about next to nothing but afrezza since you opened your twitter account last August! Presidential elections come and go; major sporting events pass by; all kinds of interesting news in the world but every comment I looked at by you was about afrezza!
3) By the same token you also post about Mannkind Corp. on "stocktwits":
And again, it's about nothing but Mannkind and afrezza! And not just an occasional message, but a relentless stream of messages sometimes 5-10 times a day!
These observations recalled to mind something Amy Tenderich pointed out in her own article, "Six Things to Know Before Starting Afrezza":
"6) ePatients Beware – If you plan to blog, or in particular, Tweet about your experiences with Afrezza, beware investor trolls! They are mostly obvious with brand new Twitter accounts showing only an “egghead” profile pic, and a timeline that talks nothing but #Afrezza. Some are more subtle. But all are pretty ruthless in their attempts to control the message in the interest of influencing MannKind stock prices to their own advantage. I guarantee that unless you are saying 100% glowingly positive things about Afrezza all the time, you will be hounded and patronized."